Insider · CIK 0001235635

GRAHAM PETER J

Reports to the SEC for 4 companies · NEW PROVIDENCE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001235635

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	ADCTADC Therapeutics SAA Award	Chief Legal Officer	AAward	+221K sh	—	—	841,640
2026-02-13	ADCTADC Therapeutics SAF Tax Payment	Chief Legal Officer	FTax Payment	−33.3K sh	$3.99	−$133K	620,540
2026-02-13	ADCTADC Therapeutics SAA Award	Chief Legal Officer	AAward	+295K sh	$3.99	+$1.18M	653,834
2025-12-06	ADCTADC Therapeutics SAF Tax Payment	Chief Legal Officer	FTax Payment	−49.5K sh	$3.29	−$163K	359,034
2025-02-13	ADCTADC Therapeutics SAA Award	Chief Legal Officer	AAward	+220K sh	$1.61	+$354K	408,542
2024-12-06	ADCTADC Therapeutics SAF Tax Payment	Chief Legal Officer	FTax Payment	−41.5K sh	$3.13	−$130K	188,542
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−254K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−170K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−164K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−414K sh	$5.60	−$2.32M	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−202K sh	$5.60	−$1.13M	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−124K sh	$5.60	−$696K	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−125K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−213K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−218K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−177K sh	—	—	0
2022-03-03	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−13.6K sh	$3.80	−$51.8K	616,609
2022-03-03	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+26K sh	—	—	630,244
2022-02-16	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+23.1K sh	—	—	617,499
2022-02-16	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−13.3K sh	$3.66	−$48.7K	604,200
2021-06-13	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−14.8K sh	$4.45	−$65.8K	594,431
2021-06-11	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−23K sh	$4.45	−$102K	609,221
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+164K sh	—	—	163,963
2021-06-10	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+86K sh	$4.42	+$380K	632,231
2021-06-08	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−16K sh	$4.39	−$70.2K	546,258
2021-03-01	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−24K sh	$4.50	−$108K	562,254
2021-03-01	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+45.8K sh	—	—	586,246
2021-02-18	ANTARES PHARMA, INC.S Sale	See Remarks	SSale	−5,000 sh	$5.05	−$25.3K	540,417
2021-02-18	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	+45K sh	—	—	0
2021-02-18	ANTARES PHARMA, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+45K sh	$1.12	+$50.4K	585,417
2021-02-18	ANTARES PHARMA, INC.S Sale	See Remarks	SSale	−40K sh	$4.91	−$196K	545,417
2021-02-17	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+80.4K sh	—	—	582,490
2021-02-17	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−42.1K sh	$4.73	−$199K	540,417
2020-06-13	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−15K sh	$2.78	−$41.8K	502,125
2020-06-11	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+132K sh	$2.73	+$360K	517,161
2020-06-11	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+254K sh	—	—	254,165
2020-06-08	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−16.3K sh	$3.13	−$50.9K	385,293
2020-06-07	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−18K sh	$3.12	−$56.1K	401,554
2020-02-19	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−29.9K sh	$3.53	−$106K	419,548
2020-02-19	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+63.2K sh	—	—	449,495
2019-06-13	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+84.8K sh	$2.92	+$247K	386,261
2019-06-13	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+170K sh	—	—	170,227
2019-06-08	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−11.7K sh	$2.81	−$32.8K	301,501
2019-06-07	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−12.9K sh	$2.81	−$36.3K	313,179
2019-06-02	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−15.4K sh	$2.79	−$43K	326,101
2019-02-20	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−32.4K sh	$3.20	−$104K	341,522
2019-02-20	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+84.7K sh	—	—	373,908
2018-06-08	ANTARES PHARMA, INC.A Award	See Remarks	AAward	+91.7K sh	$2.70	+$248K	289,173
2018-06-08	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	See Remarks	AAward	+177K sh	—	—	177,453
2018-06-07	ANTARES PHARMA, INC.F Tax Payment	See Remarks	FTax Payment	−12.9K sh	$2.70	−$34.9K	197,506

Recent filings

Accepted (ET)
Jul 24
GRAHAM PETER J0001628280-26-047034
SEC(opens sec.gov)
Feb 184
GRAHAM PETER J0001628280-26-009280
SEC(opens sec.gov)
Dec 94
GRAHAM PETER J0001628280-25-056169
SEC(opens sec.gov)
Feb 144
GRAHAM PETER J0001628280-25-005863
SEC(opens sec.gov)
Dec 94
GRAHAM PETER J0001628280-24-050540
SEC(opens sec.gov)
May 264
GRAHAM PETER J0000899243-22-019789
SEC(opens sec.gov)
Mar 44
GRAHAM PETER J0001016169-22-000031
SEC(opens sec.gov)
Feb 184
GRAHAM PETER J0001016169-22-000016
SEC(opens sec.gov)

Companies

Address

430 MOUNTAIN AVENUE, SUITE 404

NEW PROVIDENCE, NJ, 07974